[Benefit of elective percutaneous coronary intervention for stable coronary artery disease].

[1]  J. Hochman,et al.  Planning and Conducting the ISCHEMIA Trial. , 2018, Circulation.

[2]  S. Thom,et al.  Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial , 2018, The Lancet.

[3]  Lesli S. Ott,et al.  Practice‐Level Variation in Outpatient Cardiac Care and Association With Outcomes , 2016, Journal of the American Heart Association.

[4]  Regina M. Hardison,et al.  Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials. , 2014, JAMA internal medicine.

[5]  Lisa Rosenbaum,et al.  Cents and sensitivity. Teaching physicians to think about costs. , 2012, Minnesota medicine.

[6]  Nikola Jagic,et al.  Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. , 2012, The New England journal of medicine.

[7]  J. Spertus,et al.  Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease. , 2009, The American journal of cardiology.

[8]  Regina M. Hardison,et al.  A randomized trial of therapies for type 2 diabetes and coronary artery disease. , 2009, The New England journal of medicine.

[9]  Grace A Lin,et al.  Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. , 2008, JAMA.

[10]  D. Berman,et al.  Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.

[11]  F. L. Lucas,et al.  Temporal Trends in the Utilization of Diagnostic Testing and Treatments for Cardiovascular Disease in the United States, 1993–2001 , 2006, Circulation.

[12]  Thomas E. Moritz,et al.  Coronary-artery revascularization before elective major vascular surgery , 2005 .

[13]  D. Berman,et al.  Comparison of the Short‐Term Survival Benefit Associated With Revascularization Compared With Medical Therapy in Patients With No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed Tomography , 2003, Circulation.

[14]  D. Baim,et al.  Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. , 1999, The New England journal of medicine.

[15]  RITA-2 trial participants.  Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial , 1997, The Lancet.